Literature DB >> 8289380

High-level expression and purification of secreted forms of herpes simplex virus type 1 glycoprotein gD synthesized by baculovirus-infected insect cells.

W P Sisk1, J D Bradley, R J Leipold, A M Stoltzfus, M Ponce de Leon, M Hilf, C Peng, G H Cohen, R J Eisenberg.   

Abstract

Two forms of herpes simplex virus glycoprotein gD were recombined into Autographa californica nuclear polyhedrosis virus (baculovirus) and expressed in infected Spodoptera frugiperda (Sf9) cells. Each protein was truncated at residue 306 of mature gD. One form, gD-1(306t), contains the coding sequence of Patton strain herpes simplex virus type 1 gD; the other, gD-1(QAAt), contains three mutations which eliminate all signals for addition of N-linked oligosaccharides. Prior to recombination, each gene was cloned into the baculovirus transfer vector pVT-Bac, which permits insertion of the gene minus its natural signal peptide in frame with the signal peptide of honeybee melittin. As in the case with many other baculovirus transfer vectors, pVT-Bac also contains the promoter for the baculovirus polyhedrin gene and flanking sequences to permit recombination into the polyhedrin site of baculovirus. Each gD gene was engineered to contain codons for five additional histidine residues following histidine at residue 306, to facilitate purification of the secreted protein on nickel-containing resins. Both forms of gD-1 were abundantly expressed and secreted from infected Sf9 cells, reaching a maximum at 96 h postinfection for gD-1(306t) and 72 h postinfection for gD-1(QAAt). Secretion of the latter protein was less efficient than gD-1(306t), possibly because of the absence of N-linked oligosaccharides from gD-1(QAAt). Purification of the two proteins by a combination of immunoaffinity chromatography, nickel-agarose chromatography, and gel filtration yielded products that were > 99% pure, with excellent recovery. We are able to obtain 20 mg of purified gD-1(306t) and 1 to 5 mg of purified gD-1(QAAt) per liter of infected insect cells grown in suspension. Both proteins reacted with monoclonal antibodies to discontinuous epitopes, indicating that they retain native structure. Use of this system for gD expression makes crystallization trials feasible.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8289380      PMCID: PMC236513          DOI: 10.1128/JVI.68.2.766-775.1994

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  Localization of discontinuous epitopes of herpes simplex virus glycoprotein D: use of a nondenaturing ("native" gel) system of polyacrylamide gel electrophoresis coupled with Western blotting.

Authors:  G H Cohen; V J Isola; J Kuhns; P W Berman; R J Eisenberg
Journal:  J Virol       Date:  1986-10       Impact factor: 5.103

2.  Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. IV. Recognition and activation by cloned glycoproteins gB and gD.

Authors:  J M Zarling; P A Moran; R L Burke; C Pachl; P W Berman; L A Lasky
Journal:  J Immunol       Date:  1986-06-15       Impact factor: 5.422

3.  Antigenic structure and variation in an influenza virus N9 neuraminidase.

Authors:  R G Webster; G M Air; D W Metzger; P M Colman; J N Varghese; A T Baker; W G Laver
Journal:  J Virol       Date:  1987-09       Impact factor: 5.103

4.  Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 A resolution.

Authors:  J N Varghese; W G Laver; P M Colman
Journal:  Nature       Date:  1983 May 5-11       Impact factor: 49.962

5.  Protection from genital herpes simplex virus type 2 infection by vaccination with cloned type 1 glycoprotein D.

Authors:  P W Berman; T Gregory; D Crase; L A Lasky
Journal:  Science       Date:  1985-03-22       Impact factor: 47.728

6.  DNA sequence of the gene for pseudorabies virus gp50, a glycoprotein without N-linked glycosylation.

Authors:  E A Petrovskis; J G Timmins; M A Armentrout; C C Marchioli; R J Yancey; L E Post
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

7.  Soluble forms of herpes simplex virus glycoprotein D bind to a limited number of cell surface receptors and inhibit virus entry into cells.

Authors:  D C Johnson; R L Burke; T Gregory
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

8.  Modification and secretion of human interleukin 2 produced in insect cells by a baculovirus expression vector.

Authors:  G E Smith; G Ju; B L Ericson; J Moschera; H W Lahm; R Chizzonite; M D Summers
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

9.  The contribution of cysteine residues to antigenicity and extent of processing of herpes simplex virus type 1 glycoprotein D.

Authors:  W C Wilcox; D Long; D L Sodora; R J Eisenberg; G H Cohen
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

10.  Comparative study on O-linked oligosaccharides of glycoprotein D of herpes simplex virus types 1 and 2.

Authors:  F Serafini-Cessi; F Dall'Olio; N Malagolini; L Pereira; G Campadelli-Fiume
Journal:  J Gen Virol       Date:  1988-04       Impact factor: 3.891

View more
  64 in total

1.  Localization of the gD-binding region of the human herpes simplex virus receptor, HveA.

Authors:  J C Whitbeck; S A Connolly; S H Willis; W Hou; C Krummenacher; M Ponce de Leon; H Lou; I Baribaud; R J Eisenberg; G H Cohen
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

2.  Effects of herpes simplex virus on structure and function of nectin-1/HveC.

Authors:  Claude Krummenacher; Isabelle Baribaud; James F Sanzo; Gary H Cohen; Roselyn J Eisenberg
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

3.  Glycoprotein D of herpes simplex virus (HSV) binds directly to HVEM, a member of the tumor necrosis factor receptor superfamily and a mediator of HSV entry.

Authors:  J C Whitbeck; C Peng; H Lou; R Xu; S H Willis; M Ponce de Leon; T Peng; A V Nicola; R I Montgomery; M S Warner; A M Soulika; L A Spruce; W T Moore; J D Lambris; P G Spear; G H Cohen; R J Eisenberg
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

4.  Striking similarity of murine nectin-1alpha to human nectin-1alpha (HveC) in sequence and activity as a glycoprotein D receptor for alphaherpesvirus entry.

Authors:  D Shukla; M C Dal Canto; C L Rowe; P G Spear
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

5.  Specific association of glycoprotein B with lipid rafts during herpes simplex virus entry.

Authors:  Florent C Bender; J Charles Whitbeck; Manuel Ponce de Leon; Huan Lou; Roselyn J Eisenberg; Gary H Cohen
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

6.  Cascade of events governing cell-cell fusion induced by herpes simplex virus glycoproteins gD, gH/gL, and gB.

Authors:  Doina Atanasiu; Wan Ting Saw; Gary H Cohen; Roselyn J Eisenberg
Journal:  J Virol       Date:  2010-09-22       Impact factor: 5.103

7.  Herpes simplex virus type 1 glycoprotein e is required for axonal localization of capsid, tegument, and membrane glycoproteins.

Authors:  Fushan Wang; Waixing Tang; Helen M McGraw; Jean Bennett; Lynn W Enquist; Harvey M Friedman
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

8.  Structure of unliganded HSV gD reveals a mechanism for receptor-mediated activation of virus entry.

Authors:  Claude Krummenacher; Vinit M Supekar; J Charles Whitbeck; Eric Lazear; Sarah A Connolly; Roselyn J Eisenberg; Gary H Cohen; Don C Wiley; Andrea Carfí
Journal:  EMBO J       Date:  2005-11-17       Impact factor: 11.598

9.  Interaction with coxsackievirus and adenovirus receptor, but not with decay-accelerating factor (DAF), induces A-particle formation in a DAF-binding coxsackievirus B3 isolate.

Authors:  Aaron M Milstone; JenniElizabeth Petrella; Melissa D Sanchez; Mariam Mahmud; J Charles Whitbeck; Jeffrey M Bergelson
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

10.  Protection provided by a herpes simplex virus 2 (HSV-2) glycoprotein C and D subunit antigen vaccine against genital HSV-2 infection in HSV-1-seropositive guinea pigs.

Authors:  Sita Awasthi; John W Balliet; Jessica A Flynn; John M Lubinski; Carolyn E Shaw; Daniel J DiStefano; Michael Cai; Martha Brown; Judith F Smith; Rose Kowalski; Ryan Swoyer; Jennifer Galli; Victoria Copeland; Sandra Rios; Robert C Davidson; Maya Salnikova; Susan Kingsley; Janine Bryan; Danilo R Casimiro; Harvey M Friedman
Journal:  J Virol       Date:  2013-11-27       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.